Cerezyme 400 unit vials
Ended Awarded Last action
- Contract number
- SPE2DR26FSCB6
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $18,891
Award facts
- Contract value 100% obligated
- $18,890.64 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $18,890.64 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, for the supply of Cerezyme 400 unit vials. The award was issued on December 16, 2025, with an ultimate completion date of January 8, 2026, and carries no set-aside designation. DMS Pharmaceutical Group will perform the work at its Park Ridge facility and serve as the sole contractor on this delivery order with no identified subcontractors.
This delivery order is issued under DMS Pharmaceutical Group's Indefinite Delivery Contract with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a $30.3 billion government-wide acquisition strategy established to provide comprehensive pharmaceutical and medical supply support to Department of Defense healthcare facilities worldwide. The underlying IDC, valued at $499,999,999 with a completion date of December 31, 2036, positions DMS Pharmaceutical Group as one of multiple regional prime vendors authorized to supply branded and generic prescription drugs, biologics, and medical consumables. The company's demonstrated performance across numerous delivery orders for specialized pharmaceutical products including oncology treatments, biologics, vaccines, and emergency medications reflects its established capability to meet the diverse medical supply requirements of the federal military healthcare system.
Quick answers
Who was awarded contract SPE2DR26FSCB6?
SPE2DR26FSCB6 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on December 16, 2025.
How much is contract SPE2DR26FSCB6 worth?
The government has obligated $18,891 on SPE2DR26FSCB6.
Is contract SPE2DR26FSCB6 an order under another contract?
Yes. SPE2DR26FSCB6 is a delivery order under SPE2DR25D9316, an indefinite delivery contract.
Was contract SPE2DR26FSCB6 competed?
The extent of competition for SPE2DR26FSCB6 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award